• Methanogens, Methane and Gastrointestinal Motility.

• Small intestinal bacterial overgrowth: what it is and what it is not.

• Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype.

• Prolonged orocecal transit time enhances serum bile acids through bacterial overgrowth, contributing factor to gallstone disease.

• Increasing duodenal intraepithelial lymphocytosis found at upper endoscopy: time trends and associations.

• In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth.

• SIBO in Gastroparesis: Sci-fi or Science Fact?

• Small intestinal bacterial overgrowth in gastroparesis.

• The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth.

• The prevalence of small intestinal bacterial overgrowth and methane production in patients with myelomeningocele and constipation.

• Ascorbic acid suppresses endotoxemia and NF-?B signaling cascade in alcoholic liver fibrosis in guinea pigs: a mechanistic approach.

• Pathological bacterial translocation in liver cirrhosis.

By Cedars-Sinai Team/ Dr Pimentel:

• History of Tonsillectomy is Associated with IBS. – letter to the editor

• Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.

• Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome.

• Acute and Chronic Histological Changes of the Small Bowel Secondary to C. jejuni Infection in a Rat Model for Post-Infectious IBS.

• Inflammation and microflora.

• Importance of Diarrhea in Evaluating Constipation in Irritable Bowel Syndrome Clinical Studies.

• Methane on breath testing is associated with constipation: a systematic review and meta-analysis.

• Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.

• Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS.

• Rifaximin therapy for patients with irritable bowel syndrome without constipation.

• Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome.

By Dr Weinstock (& associates):

• Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome.

• Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.

• Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.

• Rosacea in Crohn’s Disease: Effect of Rifaximin.

By Rome, Italy team:

• Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

• Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease.

Others:

• Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth.

• Gastrointestinal transit in patients with systemic sclerosis.

• Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?

• When to reconsider the diagnosis of irritable bowel syndrome.

• Probable interaction between warfarin and rifaximin in a patient treated for small intestine bacterial overgrowth.

• Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.

• Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors.

• Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.

• Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

• The role of small intestinal bacterial overgrowth in postgastrectomy patients.

• Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.

• Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

• Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.